Low Rate of Referral for Low-Vision Rehabilitation

Share this content:
Low Rate of Referral for Low-Vision Rehabilitation
Low Rate of Referral for Low-Vision Rehabilitation

MONDAY, March 19, 2018 (HealthDay News) -- Few patients with irreversible vision impairment are referred for vision rehabilitation, according to a study published online March 15 in JAMA Ophthalmology.

M. Austin Coker, from the University of Alabama at Birmingham, and colleagues examined the rate of referral for low-vision rehabilitation services by resident and attending ophthalmologists for adults with irreversible vision impairment. A total of 143 adults aged 18 years or older seen in a publicly funded comprehensive eye clinic and with one or both eyes with irreversible vision impairment were enrolled.

The researchers found that the rate of referral for low-vision rehabilitation services was 11.4 and 1.9 percent for patients with irreversible bilateral vision impairment and unilateral impairment, as noted in the electronic health record. Most patients with bilateral and unilateral impairment indicated being bothered by their vision impairment (91.2 and 92.8 percent, respectively); most reported difficulty with reading (97.1 and 81.7 percent with bilateral and unilateral impairment, respectively).

"Results of this study suggest a need to better educate ophthalmologists and residents in ophthalmology about referrals to low-vision rehabilitation services for patients with irreversible vision impairment," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Increase Seen in Salmonella Illnesses From Ground Beef

CDC: Increase Seen in <i>Salmonella</i> Illnesses From Ground ...

246 people now sickened; 59 people have been hospitalized; no deaths reported to date

Epinephrine Personal Autoinjectors Cost-Effective at 24

Epinephrine Personal Autoinjectors Cost-Effective at &#36;24

Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24

Burden of Liver Cancer Rising in Medicare Patients

Burden of Liver Cancer Rising in Medicare Patients

Coexistence of other liver conditions tied to even higher risk for death, health care costs

is free, fast, and customized just for you!




Already a member?

Sign In Now »